HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Anticancer Drug Formulation

Anticancer Drug Formulation

In the realm of cancer research, the formulation of anticancer drugs represents a cornerstone in the fight against this formidable disease. Scientists continually innovate to develop drug formulations that target cancer cells while minimizing damage to healthy tissues. Nanotechnology has emerged as a promising avenue, enabling the precise delivery of therapeutic agents directly to tumors, thereby enhancing efficacy and reducing side effects. Furthermore, advancements in personalized medicine have led to tailored drug formulations based on an individual's genetic makeup and the specific characteristics of their cancer. By harnessing cutting-edge technologies and interdisciplinary approaches, researchers strive to develop increasingly sophisticated anticancer drug formulations that offer improved outcomes and better quality of life for patients battling cancer.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp